Enlivex anticipates releasing topline data from the Phase II stage, including full three-month endpoints, by this August.

Results presented here showed intra-articular injections of platelet-rich plasma may be inferior to corticosteroid injections ...

Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis ...

Enlivex believes Allocetra™ has the potential to transform osteoarthritis treatment ... and tolerability of Allocetra™ injections to the target knee, in order to identify the dose and ...

Swiss pharma major Novartis has discontinued development of its experimental treatment QUC398 for knee osteoarthritis, ending ...

The Department of Health - Abu Dhabi (DoH), has successfully completed a groundbreaking clinical trial in Abu Dhabi, in ...

The Arthritis Knee Pain Centers (AKPC) and Dr. John Rush, its owner and Chief Executive Officer, face False Claims Act ...

MSK Doctors has released a new report detailing the positive impact that Arthrosamid has had on recent knee osteoarthritis patients, exploring the innovative hydrogel injection treatment in depth.

With Japan’s rapidly aging population, the prevalence of knee osteoarthritis is expected to rise. This has led to an increased demand for non-surgical treatment options, such as knee hyaluronic acid ...

Yoga is as effective for addressing knee pain due to osteoarthritis as muscle-strengthening exercises, according to a new study. The new randomized clinical trial has also found that yoga may ...